L. Lazarou

1.7k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

L. Lazarou is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, L. Lazarou has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Genetics and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in L. Lazarou's work include Genetic Neurodegenerative Diseases (9 papers), Genetic and Kidney Cyst Diseases (6 papers) and Genetics and Neurodevelopmental Disorders (5 papers). L. Lazarou is often cited by papers focused on Genetic Neurodegenerative Diseases (9 papers), Genetic and Kidney Cyst Diseases (6 papers) and Genetics and Neurodevelopmental Disorders (5 papers). L. Lazarou collaborates with scholars based in United Kingdom, Australia and United States. L. Lazarou's co-authors include Peter S. Harper, Russell G. Snell, Duncan J. Shaw, Jeremy P. Cheadle, Iain Fenton, Peter J. Davies, John MacMillan, Marcy E. MacDonald, James F. Gusella and Audrey Tyler and has published in prestigious journals such as The Lancet, Nucleic Acids Research and Nature Genetics.

In The Last Decade

L. Lazarou

26 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease

1993 558 citations Russell G. Snell, John MacMillan et al. Nature Genetics profile →

Peers

Countries citing papers authored by L. Lazarou

Since Specialization

Citations

This map shows the geographic impact of L. Lazarou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Lazarou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Lazarou more than expected).

Fields of papers citing papers by L. Lazarou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Lazarou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Lazarou. The network helps show where L. Lazarou may publish in the future.

Co-authorship network of co-authors of L. Lazarou

This figure shows the co-authorship network connecting the top 25 collaborators of L. Lazarou. A scholar is included among the top collaborators of L. Lazarou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Lazarou. L. Lazarou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MECP2 triplication in 3 brothers – A rarely described cause of familial neurological regression in boys 2011 ·European Journal of Paediatric Neurology ·Shan Tang, (unknown), L. Lazarou, Rahul Singh, Penny Fallon	23
2	An isolated case of lissencephaly caused by the insertion of a mitochondrial genome-derived DNA sequence into the 5' untranslated region of the PAFAH1B1 (LIS1) gene 2010 ·Human Genomics ·David Millar, Carolyn Tysoe, L. Lazarou, Daniela T. Pilz, Shehla Mohammed, (unknown), Nadia Chuzhanova, D.N. Cooper, Rachel Butler	9
3	High frequency of genomic deletions—and a duplication—in the LIS1 gene in lissencephaly: implications for molecular diagnosis 2008 ·Journal of Medical Genetics ·Davide Mei, Ruth Lewis, Elena Parrini, L. Lazarou, Carla Marini, Daniela T. Pilz, Renzo Guerrini	30
4	Two sisters with Rett syndrome and non-identical paternally-derived microdeletions in the MECP2 gene 2008 ·PubMed ·(unknown), Shane McKee, (unknown), Hayley Archer, James B. Hughes, Rachel Butler, Nadia Chuzhanova, D.N. Cooper, L. Lazarou	4
5	NTNG1 mutations are a rare cause of Rett syndrome 2006 ·American Journal of Medical Genetics Part A ·Hayley Archer, Julie Evans, David Millar, Peter Thompson, Alison Kerr, Helen Leonard, John Christodoulou, David Ravine, L. Lazarou, (unknown), Christopher Verity, Sharon D. Whatley, Daniela T. Pilz, Julian R. Sampson, Angus Clarke	38
6	Early onset seizures and Rett-like features associated with mutations in CDKL5 2005 ·European Journal of Human Genetics ·Julie Evans, Hayley Archer, James Colley, Kirstine Ravn, Jytte Bieber Nielsen, Alison Kerr, Elizabeth Williams, John Christodoulou, Jozef Gécz, Philip Jardine, Michael Wright, Daniela T. Pilz, L. Lazarou, D.N. Cooper, Julian R. Sampson, Rachel Butler, Sharon D. Whatley, Angus Clarke	135
7	Co-occurrence of autosomal dominant polycystic kidney disease and Marfan syndrome in a kindred 2000 ·American Journal of Kidney Diseases ·Nick Hateboer, Maurice Buchalter, Sarah Davies, L. Lazarou, David Ravine	17
8	Familial phenotype differences in PKD1 1999 ·Kidney International ·Nick Hateboer, L. Lazarou, Andrew J Williams, Peter Holmans, David Ravine	46
9	Characterization of 34 novel and six known MTM1 gene mutations in 47 unrelated X-linked myotubular myopathy patients 1999 ·Neuromuscular Disorders ·Stephan M. Tanner, Vreni Schneider, Nick Thomas, Angus Clarke, L. Lazarou, Sabina Liechti‐Gallati	34
10	Novel and recurrent mutations in the PKD1 (Polycystic Kidney disease) gene 1998 ·Human Genetics ·(unknown), Magitha M. Maheshwar, L. Lazarou, (unknown), (unknown), David Ravine	28
11	Immunohistological evidence for second or somatic mutations as the underlying cause of dystrophin expression by isolated fibres in Xp21 muscular dystrophy of Duchenne-type severity 1993 ·Journal of the Neurological Sciences ·Carina Wallgren‐Pettersson, Bharat Jasani, (unknown), L. Lazarou, L. V. B. Nicholson, (unknown)	18
12	Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease breakdown → 1993 ·Nature Genetics ·Russell G. Snell, John MacMillan, Jeremy P. Cheadle, Iain Fenton, L. Lazarou, Peter J. Davies, Marcy E. MacDonald, James F. Gusella, Peter S. Harper, Duncan J. Shaw	558
13	Huntington's disease: predictive testing and the molecular genetics laboratory 1993 ·Clinical Genetics ·L. Lazarou, Andrea L. Meredith, J Myring, Audrey Tyler, Michael J. Morris, (unknown), Peter S. Harper	2
14	Molecular analysis and clinical correlations of the Huntington's disease mutation 1993 ·The Lancet ·J. MacMillan, Russell G. Snell, Audrey Tyler, (unknown), Iain Fenton, Jeremy P. Cheadle, L. Lazarou, (unknown), Peter S. Harper	77
15	Presymptomatic Testing for Huntington's Disease in Wales 1987–90 1992 ·The British Journal of Psychiatry ·Audrey Tyler, Michael J. Morris, L. Lazarou, Linda Meredith, (unknown), Peter S. Harper	26
16	Five years experience of predictive testing for myotonic dystrophy using linked DNA markers 1992 ·American Journal of Medical Genetics ·William Reardon, (unknown), J Myring, L. Lazarou, Andrea L. Meredith, Peter S. Harper	9
17	Mbol RFLP at the D4S43 (C4H) locus 1991 ·Nucleic Acids Research ·L. Lazarou, Russell G. Snell, Marcy E. MacDonald, James F. Gusella, John J. Wasmuth, (unknown)	1
18	PROBLEMS IN GENETIC PREDICTION FOR HUNTINGTON'S DISEASE 1989 ·The Lancet ·(unknown), L. Lazarou, Audrey Tyler, Linda Meredith, Peter S. Harper	35
19	RFLP for the human erb-Aβlocus 1988 ·Nucleic Acids Research ·Fiona S. Wyllie, L. Lazarou, David Wynford‐Thomas	3
20	Mutations for the autosomal recessive and autosomal dominant forms of polycystic kidney disease are not allelic 1988 ·Human Genetics ·Michèle Ramsay, Stephen T. Reeders, Peter D. Thomson, Lawrence S. Milner, L. Lazarou, T M Barratt, (unknown), Ordan J. Lehmann, Trefor Jenkins	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact